Source: Olivier Chassignole/AFP via Getty Images
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • The Federal Government had decided against ordering any single-dose COVID-19 vaccines from drugmaker Johnson & Johnson, despite a shortage of jabs
  • The Morrison Government is under increasing pressure to secure more vaccines for Australia after the AstraZeneca jab was ruled out for under-50s
  • But, Health Minister Greg Hunt’s office said the Johnson & Johnson vaccine was too similar to AstraZeneca’s jab to be considered an alternative
  • His decision comes as Australia recorded its first death from COVID-19 after an 80-year-old man from the Philippines died in hospital in Brisbane
  • The deceased man tested positive for the virus late last month while in hotel quarantine and passed away on April 12

The Federal Government had announced it won’t be ordering any single-dose COVID-19 vaccines from drugmaker Johnson & Johnson.

The decision comes despite the Morrison Government falling under increasing pressure to secure more vaccines after the AstraZeneca jab was ruled out for under-50s due to a rare blood clotting risk.

But, Health Minister Greg Hunt’s office has told the ABC that the Johnson & Johnson vaccine, which is being used throughout the U.S., was too similar to AstraZeneca’s jab to be considered a viable replacement.

The government’s decision comes as Australia recorded its first death from COVID-19 in recent months, with an 80-year-old man from the Philippines dying in hospital in Brisbane.

Local health authorities said the deceased man tested positive for the virus late last month while in hotel quarantine in the state before he passed away while in hospital care on Monday, April 12.

Meanwhile, Labor has intensified its attacks on the Federal Government’s handling of the vaccine rollout — accusing it of “botching” the plan.

Former Opposition Leader Bill Shorten said the government must act to restore confidence in the jab rollout.

“It’s a very bad week for timelines for Australians. The reality is that Australians are being held hostage to a botched vaccine rollout,” he told Nine.

“I mean, people were hoping that the vaccines were a path or a ticket back to normal. But now we find out that travel might not be a thing until 2024,” he said.

“It’s really, I think, undermined the confidence of a lot of Australians, especially younger ones, in the vaccine program full stop. It’s very bad news,” he added.

More From The Market Online

Well below US$5K/oz, gold’s surefire status as a safe haven has shifted

In the post-COVID-19 world, it’s almost definitely news to nobody reading this that gold prices have staged a fairly historic run.
The Market Online Video

From the Wire: Why did the RBA cut last year just to walk it all back 12 months later?

The Reserve Bank of Australia made the call to hike interest rates again in CY26, using its second board meeting to bring them
ASX concept

ASX 200 reacts to an RBA 25bps rate hike by… closing somewhat firmly in the green?

Colour me surprised – the ASX200 successfully priced something in for once, with today’s RBA rate hike not scaring the market down into
India Russia flag

Not just AUKUS indexes: USA’s war on Iran visible on India’s NIFTY; Russia’s MOEX

While the Australian market is busy watching Wall Street, gold, and oil prices – and the prices of relevant stocks exposed to those